ArticleCancers2019

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer.

Cristina Raimondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.